1
|
Mutations in SOX2 cause anophthalmia.
|
Nat Genet
|
2003
|
5.03
|
2
|
Heterozygous mutations of OTX2 cause severe ocular malformations.
|
Am J Hum Genet
|
2005
|
2.26
|
3
|
SOX2 anophthalmia syndrome.
|
Am J Med Genet A
|
2005
|
2.24
|
4
|
Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways.
|
Am J Hum Genet
|
2008
|
1.86
|
5
|
Outcome following surgery for contact lens-induced ptosis.
|
Ophthal Plast Reconstr Surg
|
2011
|
1.45
|
6
|
Novel heterozygous OTX2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma.
|
Hum Mutat
|
2008
|
1.21
|
7
|
Seeing clearly: the dominant and recessive nature of FOXE3 in eye developmental anomalies.
|
Hum Mutat
|
2009
|
1.20
|
8
|
Trachomatous trichiasis and its management in endemic countries.
|
Surv Ophthalmol
|
2012
|
1.13
|
9
|
Orbitotemporal neurofibromatosis. Clinical features and surgical management.
|
Ophthalmology
|
2004
|
1.05
|
10
|
Early midline interactions are important in mouse optic chiasm formation but are not critical in man: a significant distinction between man and mouse.
|
Eur J Neurosci
|
2006
|
0.98
|
11
|
Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.
|
Hum Genet
|
2009
|
0.94
|
12
|
Eyelid reconstruction: the state of the art.
|
Curr Opin Otolaryngol Head Neck Surg
|
2004
|
0.92
|
13
|
A surgical strategy for the correction of Fraser syndrome cryptophthalmos.
|
Ophthalmology
|
2009
|
0.89
|
14
|
Innervation and secretory function of transplanted human submandibular salivary glands.
|
Transplantation
|
2008
|
0.88
|
15
|
The surgical management of childhood orbito-temporal neurofibromatosis.
|
Br J Plast Surg
|
2003
|
0.86
|
16
|
Ophthalmic experience with submandibular gland transplantation for severe dry eyes.
|
Laryngoscope
|
2009
|
0.77
|
17
|
Kinematic analysis in oculoplastic reconstructive surgery: measuring manual control and fluidity of movement.
|
Arch Ophthalmol
|
2012
|
0.75
|
18
|
Training and oculoplastics: past, present and future.
|
Orbit
|
2013
|
0.75
|